Patent classifications
G01N2001/302
SICKLE CELL POTENCY ASSAY
Disclosed herein are potency assays for a gene therapy treatment for sickle cell disease. Also disclosed herein are methods for measuring relative potency of a drug product used for the treatment of sickle cell disease.
LYOPHILIZED ANTIBODY PANEL
A lyophilized antibody panel is disclosed for interrogation using elemental analysis. The antibody panel includes multiple antibodies each element-tagged or element-labelled with one or more isotopes such that each different antibody is isotopically distinguishable from the other antibodies. Each element tag can include one or more unique isotopes or unique combinations of isotopes. The set of element-tagged antibodies can be lyophilized in admixture. Thus, the lyophilized element-tagged antibody panel can be easily and efficiently resuspended and mixed with a sample prior to interrogation with an elemental analyzer, such as a mass spectrometer. This lyophilized element-tagged antibody panel can provide the benefits of an element-tagged assay while also being easy to use and remaining stable for long durations.
FAST STAINING OF BIOMATERIALS ENHANCED BY IMAGE PROCESSING AND ARTIFICIAL INTELLIGENCE
Among other things, the present invention provides devices and methods that stain a sample simply (e.g. one step) and quickly (e.g. <60 seconds), image it without wash, and generate, by a machine learning algorithm, a final image similar to a standard staining with wash.
Method for preparing sample for X-ray imaging
The present invention addresses the problem of providing a method for observing skin tissue in which x-ray microCT is used. Adnexae such as sweat glands, sebaceous glands, and hair follicles can be identified in skin tissue by using acetone as a pretreatment solution and staining using an iodine-containing solution as a staining solution.
Devices and methods for tissue and cell staining
Devices and systems are provided herein relating to a novel and rapid assay for tissue staining. Methods for using the devices and systems for analyzing tissue samples are also disclosed.
SYNTHESIS AND APPLICATION OF FLUORESCENT DYE WITH PHENANTHRIDINE AND BENZOTHIAZOLE CONJUGATED
The disclosure relates to the field of fluorescent dyes, and provides a fluorescent dye with phenanthridine and benzothiazole conjugated. The fluorescent dye has the following structural formula:
##STR00001##
Through the above technical solution, the problems in the prior art that the fluorescent dye is susceptible to interference from other charged substances in a solution when detecting DNA so as not to be simultaneously applied to a blue light meter and an ultraviolet gel imager are solved.
Methods for Preparing Data from Tissue Sections for Machine Learning Using Both Brightfield and Fluorescent Imaging
In digital pathology, obtaining a labeled data set for training, testing and/or validation of a machine learning model is expensive, because it requires manual annotations from a pathologist. In some cases, it can be difficult for the pathologist to produce correct annotations. The present invention allows the creation of labeled data sets using fluorescent dyes, which do not affect the appearance of the slide in the brightfield imaging modality. It thus becomes possible to add correct annotations to a brightfield slide without human intervention.
Kits and Assays for Determining Bacterial Cell Viability
Provided herein are kits comprising (a) erythrosin B (EB); (b) adsorbent; and (c) instructions for use. Also provided are methods of determining the percentage of dead bacteria in a bacterial cell population. The methods comprise (a) obtaining a bacterial cell population; (b) contacting the bacterial cell population with an erythrosin B (EB) solution; (c) contacting the bacterial cell population and EB with an adsorbent to remove excess EB; (d) transferring the non-adsorbed bacterial cell population and EB solution; and (e) determining the percentage of dead bacteria in the bacterial cell population.
SILVER NANOPARTICLE SURFACE ENABLED SELF-ASSEMBLY OF ORGANIC DYE MOLECULES
Fluorescence titration of methylene blue, rhodamine B and rhodamine 6G (R6G) by silver nanoparticle (AgNP) all resulted in an initial steep quenching curve followed with a sharp turn and a much flatter quenching curve. At the turn, there are about 200,000 dye molecules per a single AgNP, signifying self-assembly of approximately 36 layers of dye molecules on the surface of the AgNP to form a micelle-like structure. These fluorescence-quenching curves fit to a mathematical model with an exponential term due to molecular self-assembly on a AgNP surface, or “self-assembly shielding effect”, and a Stern-Volmer term (nanoparticle surface enhanced quenching). Such a “super-quenching” by AgNP can only be attributed to “pre-concentration” of the dye molecules on the nanoparticle surface that yields the formation of micelle-like self-assembly, resulting in great fluorescence quenching. Overall, the fluorescence quenching titration reveals three different types of interactions of dye molecules on AgNP surface: 1) self-assembly (methylene blue, rhodamine B and R6G), 2) absorption/tight interaction (tryptamine and fluorescein), and 3) loose interaction (eosin Y). We attribute the formation of micelle-like self-assembly of these three dye molecules on AgNP to their positive charge, possession of nitrogen atoms, and with relatively large and flat aromatic moieties.
Image analysis of epithelial component of histologically normal prostate biopsies predicts the presence of cancer
A method of detecting the presence of a prostate cancer in a human subject comprising the steps of (a) obtaining a histologically normal prostate tissue sample from the patient and (b) quantifying the epithelial thickness or gland lumen roundness of the tissue, wherein an increase in epithelial thickness or a decrease in gland lumen roundness indicates the presence of prostate cancer or a prostate cancer field defect.